| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |